So goes the old and oft quoted saying. But, is this really true anymore what with the vast array of antibiotics available today and the medical fervor to treat to cure with cost thrown to the wind? Antibiotics are not generally perceived as falling into the category of aggressive treatment like cardiopulmonary resuscitation, artificial nutrition and hydration, and others. There appears to be no great ethical debate on withholding or withdrawing antibiotics or even the medical futility of their use as the end of life nears. The side effects of these drugs such as diarrhea, the risk of Clostridium difficle, bleeding due to impaired vitamin K, drug resistance, and many more are often trivialized. Do they provide comfort or more simply more discomfort? Is the principle of proportionality, that is, weighing the benefit-burden ratio, ignored?
It is in this discussion that the article by Chun et al 1 is worth noting. The authors retrospectively reviewed all patients who received inpatient palliative care consults at the 850-bed University of Michigan Health System facility over a 5-month period in 2008. Of the 131 patients seen, 70 (53.4%) were being treated with antibiotics. With a mean age of 64.5 years and male predominance (58.6%), this study group had frequent comorbid conditions such as cancer, diabetes, cardiovascular diseases, and chronic renal failure. Ninety-two infections were identified, most commonly pneumonia and bronchitis. Half the patients were treated with culture results whereas 62.9% received empiric treatment. Piperacillin/tazobactam and vancomycin were the most frequent antibiotics used. Of note, almost a quarter of the consulted patients died prior to discharge. Commenting on these results, the authors noted significant empiric use of broad spectrum antibiotics among hospitalized patients nearing death and viewed antimicrobial treatment as an aggressive modality of care.
Recognizing that there are numerous other published studies investigating the use of antibiotics in the palliative care setting, the recent abstract by Bruni et al, 2 is interesting. During a 2-week period, the authors investigated antibiotic use at St. Joseph's Hospice in London. Ten of 68 patients (14.7%) were taking oral antibiotics for urinary tract infections, chest infections, and cellulites. Only 5/10 patients had a clear indication of the expected length of antibiotic course and only 3/10 were on a regimen recommended by established guidelines.
Although this study was investigating adherence to guidelines, the similarity in the sites of infections in 2 different but similar groups of patients is obvious as is the variation in antibiotic use.
Recurrent infections are considered a marker of end-stage dementia. The use of antibiotics in these patients has been debated for years. In 1986, Volicer et al 3 published the results of their study of 40 patients with advanced dementia of Alzheimer type (DAT) using the hospice approach. One of the clinically relevant aspects of the study of Volicer et al was their identification and subsequent management of the infectious complications of this disease. Of the 40 patients, 13 died within the first year. An autopsy was performed in 11 cases, with the finding of pneumonia as the cause of death in 7 cases and sepsis resulting from urinary tract infection as the cause of death in 2 cases. Infection, therefore, was the most common cause of death in these patients. The occurrence of pneumonia was often attributed to the aspiration of solids or liquids as a consequence of dysphagia.
Sixty-two percent of the patients were not treated with antibiotics if they developed symptoms of pneumonia. The authors did not favor empiric antibiotic therapy without a work-up and speculated that the patients' comfort was maintained by the frequent use of analgesics and antipyretics. Preliminary data indicated that this hospice approach of comfort care only without antibiotics did not significantly increase the mortality of the patients with DAT.
In a follow-up of their 1986 study, Fabiszewski, Volicer, and Volicer 4 prospectively evaluated episodes of fever in 104 institutionalized patients with DAT to determine the effect of antibiotic treatment on the outcome of fever. When the source of fever was clinically apparent, broad spectrum antibiotic coverage was started after completion of the diagnostic protocol. When no source of infection was obvious, the patient was monitored and treated symptomatically with antipyretics and other comfort measures until the culture results were available. These 2 groups of patients were then compared.
A survival analysis showed that, for the more severely affected patients, there was no survival difference between the antibiotic and the comfort care group; however, among the less severely affected patients, survival was higher for the antibiotic-treated group. The authors concluded that fever is a common occurrence in institutionalized patients with Alzheimer disease and comfort care without antibiotics is an appropriate treatment option, especially for the more severely impaired patients with DAT.
In 2005, Lacey 5 published the results of a survey of nursing homes in New York State. A self-designed questionnaire investigating perceptions of key medical decision-makers regarding the use of feeding tubes, antibiotics, and hospital transfer of residents with end-stage dementia was sent to 138 nursing homes, with slightly less than half responding. Overall, only 10% of key medical decision-makers were perceived to discourage the use of antibiotics for residents with end-stage dementia. Of this group, 41% of medical directors, 59% of directors of nursing, and 57% of administrators actively encouraged antibiotic use. Based on these results, the author suggested that key medical decision-makers in nursing homes took positions inconsistent with recommendations made by dementia and palliative care experts. Furthermore, the study identified a strong need for educating nursing home administrative staff in stateof-the art care for patients with advanced dementia in nursing homes.
It is difficult to summarize this issue of antibiotic use, terminal care, and where to draw the line. But, based on this short review, the following are offered:
There appears to be widespread use of empiric antimicrobial therapy in divergent patient populations as the end of life nears. An unknown portion (? sizable) of this management is unnecessary. Antibiotics are appropriate for specific symptom management such as dysuria associated with a urinary tract infection or dysphagia from oral candida. Pneumonia may well be managed with antipyretics and opioids for dyspnea rather than antibiotics. The principle of proportionality applies, weighing the benefit-burden ratio. This includes, like all medical decision making, the patient's preferences and the medical indications. Is antibiotic therapy aggressive care or is this line softer than we think?
